| PERIOD ENDING | 4-Jul-09 | 4-Apr-09 | 27-Dec-08 | 27-Sep-08 | | Total Revenue | 1,455,400 | 1,426,200 | 1,511,500 | 1,724,800 | | Cost of Revenue | 1,065,100 | 1,081,100 | 1,133,100 | 1,290,500 | | | Gross Profit | 390,300 | 345,100 | 378,400 | 434,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 202,800 | 401,500 | 309,800 | 330,000 | | Non Recurring | 126,900 | 832,000 | 7,800 | 12,500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,600 | (888,400) | 60,800 | 91,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (4,500) | 4,500 | | Earnings Before Interest And Taxes | 60,600 | (888,400) | 56,300 | 96,300 | | Interest Expense | 20,400 | 27,500 | 28,100 | 29,000 | | Income Before Tax | 40,200 | (915,900) | 28,200 | 67,300 | | Income Tax Expense | 400 | (17,000) | (14,400) | 4,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 39,800 | (898,900) | 42,600 | 62,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 39,800 | (898,900) | 42,600 | 62,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $39,800 | ($898,900) | $42,600 | $62,700 |
|
2.03% Nasdaq 
Income Statement
